Pilar Giraldo – Medical field – Lifetime achievement Award

Posted on by ScienceFatherLeave a Comment on Pilar Giraldo – Medical field – Lifetime achievement Award

Pilar Giraldo – Medical field – Lifetime achievement Award

Dr. Pilar Giraldo distinguished academic and researcher in the field Identification of patient-reported outcome measures and patient-reported experience measures in Gaucher disease in Spain. Dr. Pilar Giraldo Castellano appears highly suitable for the Research for Lifetime Achievement Award based on her extensive contributions and accomplishments in the field of hematology, particularly focusing on rare diseases.

🌐 Professional Profile

Educations📚📚📚

  • PhD in Medicine and accredited as a Full Professor by ANECA.
  • Master’s in Research Methodology and Molecular Oncology.
  • Coordinator of Doctorate studies at University San Jorge.

  • Research and Publications:

    • Head of research group Unit 752 of the Center for Biomedical Research Network on Rare Diseases (CIBERER).
    • Published over 140 articles in peer-reviewed journals, more than 20 book chapters, and 5 monographs.
    • Holds 5 patents related to her field.

  • Leadership in Research Projects:

    • Principal Investigator in numerous significant projects, such as the National Plan project TED2021-131518B-C32.
    • Directed more than 20 doctoral theses.
    • Led various research initiatives focusing on lysosomal diseases and other hematological conditions.

  • International Recognition and Collaboration:

    • Organized national and international congresses, including the 12th EWGGD Congress in 2016.
    • Part of the Expert Committee of the IWGGD and the Task Force on GD of the EHA.
    • Collaborates extensively with international bodies and foundations.

  • Awards and Recognition:

    • Received multiple awards for her contributions and those of her research group members at national and international congresses.
    • Recognized for her innovative work in utilizing artificial intelligence and machine learning in medical research.

  • Teaching and Mentorship:

    • Directed numerous continuing education courses for physicians.

Created educational resources and has been involved in life-long learning activities.

📝🔬Publications📝🔬

  • Elstein D, Belmatoug N, Bembi B, Deegan P, Fernandez-Sasso D, Giraldo P,
    Göker-Alpan Ö, Hughes D, Lau H, Lukina E, Revel-Vilk S, Schwartz IVD, Istaiti M, Botha J,
    Gadir N, Schenk J, Zimran A; GOS Study Group. 2024. Twelve Years of the Gaucher
    Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global
    Patient Registry.J Clin Med.13-12.
  • Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart
    A, Hughes DA, Hopkin RJ, TĂžndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta
    A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V,
    Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, BrillAlmon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG.;. 2024. Head-to-head trial
    of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and
    deteriorating renal function: results from the 2-year randomised phase III BALANCE
    study. J Med Genet.21-61, pp.520-530.
  • Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, FernĂĄndezGalĂĄn MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, MadinaveitiaOchoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, GarcĂ­a-Frade LJ,
    HernĂĄndez-Rivas JM, Labbadia F, LĂłpez-Dupla JM, Lozano-Almela ML, Mora-CasterĂĄ E,
    Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, ArévaloVargas I, Andrade-Campos M, Giraldo P. Real life data: follow-up assessment on Spanish
    3
    Gaucher disease patients treated with eliglustat. TRAZELGA project.. 2023. Real life data:
    follow-up assessment on Spanish Gaucher disease patients treated with eliglustat.
    TRAZELGA project. Orphanet J Rare Dis.18-1.
  • Stanescu S, Correcher Medina P, Del Castillo FJ, Alonso Luengo O, Arto
    Millan LM, Belanger Quintana A, Camprodon Gomez M, Diez Langhetée L, Garcia Campos
    O, Matas Garcia A, Perez-Moreno J, Rubio Gribble B, Visa-Reñé N, Giraldo-Castellano P,
    O’Callaghan Gordo M. 2023. Clinical Outcomes of Patients with Chronic Neuropathic
    Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective
    Study.Biomedicines.11-10.
  • Linhart A, DostĂĄlovĂĄ G, Nicholls K, West ML, TĂžndel C, Jovanovic A, Giraldo P,
    Vujkovac B, Geberhiwot T, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Hughes. 2023.
    Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were
    previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
    Orphanet J Rare Dis. 18-1, pp.332.
  • Louw VJ, Fraser I, Giraldo P 2023. Management goals of type 1 Gaucher
    disease in South Africa: An expert Delphi consensus document on good clinical
    practice.PLoS One. 18-8.
  • Esther Valero Tena; Mercedes Roca Espiau; Jose Verdu Diaz; Jordi Diaz
    Manera; Marcio Andrade Campos; Pilar Giraldo Castellano. 2023. Advantages of digital
    technology in the assessment of bone marrow involvement in Gaucher’s disease. Front Med
    (Lausanne).

MACAEV Fliur Zainutdin – Obtaining new compounds with biological Activity – Best Researcher Award

Posted on by ScienceFatherLeave a Comment on MACAEV Fliur Zainutdin – Obtaining new compounds with biological Activity – Best Researcher Award

MACAEV Fliur Zainutdin – Obtaining new compounds with biological Activity – Best Researcher Award

Prof Dr. Macaev Fliur Zainutdin  distinguished academic and researcher in the field  Obtaining new compounds with Biological Activity. Born in 1959, Fliur Zainutdin Macaev is a doctor habilitate in organic chemistry, having achieved this title in 2002. He studied chemistry and biology at the Bashkirian State Pedagogical University and earned his PhD from the Institute of Organic Chemistry in Ufa, Bashkortostan, Russia, at the Ural Polytechnic Institute in Sverdlovsk, Russia, under the supervision of Academician Professor Ghenrikh Tolstikov in 1990. Following his doctoral studies, he pursued postdoctoral training in vitamin D3 analogues synthesis at the Institute of Organic Chemistry of the Polish Academy of Sciences (1995-1996) with Professor Jerzy Wicha and in insect-antifeedant synthesis at Wageningen Agricultural University (1998-1999) with Professor Aede de Groot. Since 1999, he has been a prominent member of the Institute of Chemistry of the Academy of Sciences of Moldova, where he serves as the head of the Laboratory of Organic Synthesis.

🌐 Professional Profile

Educations📚📚📚

Fliur Zainutdin Macaev’s educational and career achievements are notable. He was appointed as a Corresponding Member of the Academy of Sciences of Moldova in 2023. He has served as a Professor in Bioorganic Chemistry at the Institute of Chemistry in Chisinau, Moldova, since 2014, and previously held the position of Professor in Organic Chemistry there starting in 2012. He earned his Dr. habilitat in Organic Chemistry from the Institute of Chemistry in Chisinau in 2002 and was promoted to Associate Professor in Organic Chemistry in 1993.Employment  

.

Fliur Zainutdin Macaev is a distinguished member of the Moldovan Chemical Society and the Royal Society of Chemistry. His career in research has spanned several decades and institutions. Since 2023, he has been the head of the laboratory at the Institute of Chemistry of Moldova State University. Prior to this, he served as head of the laboratory at the Institute of Chemistry from 2020 to 2022 and at the Institute of Chemistry of the Academy of Sciences of Moldova from 1999 to 2019. His career at the Institute of Chemistry of the Academy of Sciences of Moldova began in 1991, where he held positions ranging from Junior Researcher to Senior Scientific Researcher before becoming a leading scientific researcher in 1995. His specialization includes organic and medicinal chemistry, environmental sciences, nano-chemistry, new catalysts (both metal-mediated and metal-free), asymmetric synthesis, ionic liquids (including magnetic ones), computer-aided molecular design, raw and waste materials chemistry, recycling materials, nano-materials, and bio-films.

current research interest

Specializing in various aspects of organic and medicinal chemistry, he is currently engaged in projects aimed at discovering new catalytic systems, both metal-based and metal-free, for the asymmetric formation of C-C, C-N, and C-P bonds. His work also includes the mechanistic investigation of reactions that proceed with high levels of regio- and stereoselectivity. He is exploring ionic liquids as green alternatives to conventional solvents and is involved in the total synthesis of biologically active compounds and their analogues, employing computer-aided molecular design and structure-activity analysis.

experience

Prof. Macaev has successfully participated in 18 international projects (INTAS projects Ref. № 2000-0711 and Ref. № 2006-8064, MD-US projects CRDF/MC2-3007 and CRDF/MERL-7031, MD-Russia project – Ref. № 06.21CRF, MD-Belarus project Ref. № 05.15BF, MD-Ukraine project Ref. № 10.820.09.01/UA, MD-Germany project Ref. № 09.820.05.08 GF, The Royal Society International Joint Project Ref. № JP090309), STCU Ref. № 5800 as well as member of a group (SCOPES, Ref. Nr.110823), and 8 national projects as coordinator (2000-2005. Ref. № 0101 MD 01915; 2006-2010. Ref. № 06.408.030F.;2011-2012. Ref. № 11.824.08.136T; 2014-2015. Ref. № 14.518.04.08A.; 2011-2014. Ref. № 11.817.08.20F.; 2011-2014. Ref. № 11.817.08.20F.; 2015-2018. Ref. № 15.817.02.17A.; 2015-2018. Ref. № 15.817.02.17A.; 2020-2023. Ref. №20.80009.5007.17).

🏆🏆Awards🏆🏆

Prof. Macaev has received numerous prestigious awards throughout his career. In 1990, he was honored with the prize for young scientific in science and engineering of the USSR, awarded in Kiev, Ukraine. In 2014, he received a Diploma from the Government of the Republic of Moldova for his outstanding results in research. He has been recognized multiple times by the Academy of Sciences of Moldova, receiving awards for scientific achievements in 2019, 2014, 2011, and 2003, as well as a Diploma for high-performance results in 2016 and the Diploma “Academic Merit” in 2014. His accolades also include several gold and silver medals from various international exhibitions. Notably, he won the Gold Medal at the International Exhibition of Scientific Research, Innovation, and Invention Pro Invent 2022 in Cluj-Napoca, Romania, and at the Inventica International Exhibition 2022. He earned Gold and Silver Medals at the International Exhibition “Expo-EUROINVENT” in Iasi, Romania, in 2022, 2021, and 2020, and Gold Medals at the “INFOINVENT” International Exhibition in Chisinau, Moldova, in 2019 and 2018. He has also been awarded Gold Medals at the International Exhibition “Expo-EUROINVENT” in Iasi, Romania, in 2017 and 2016, and at the International Exhibition “TESLA FEST” in Novi Sad, Serbia, in 2017. Additionally, he received Gold Medals at the International Expo-EUROINVENT in 2012 and 2011, and at the International Expo – Brussels EUREKA INNOVA 2010. He was awarded Bronze Medals at the International Exposition INFOINVENT in Chisinau, Moldova, in 2007 and 2004.

 

📝🔬Publications📝🔬

  1. POGREBNOI, S., RADUL, O., STINGACI, E., LUPASCU, L., VALICA, V., UNCU, L.,SMETANSCAIA, A., PETROU, A., CIRIC, A., GLAMOCLIJA, J., SOKOVIC, M., GERONIKAKI, A. MACAEV, F. Triazolium salts as antifungal agents. Synthesis, biological and in silico evaluation. Anthibiotics 2022,11(5), 588. ISSN 2079-6382. https://doi.org/10.3390/antibiotics11050588
  2. ZVEAGHINTSEVA,, STINGACI, E., POGREBNOI, S., SMETANSCAIA, A., VALICA, V., UNCU, L., KRAVTSOV, V., MELNIC, E., PETROU, A., GLAMOČLIJA, J., SOKOVIĆ, M., CARAZO, A., MLADĚNKA, P., POROIKOV, V., GERONIKAKI, A., MACAEV, F.Z. Chromenols derivatives as novel antifungal agents. Synthesis, In Silico and In Vitro Evaluation biological evaluation and molecular docking. În: Molecules, 2021, 26(14), 4304. (IF: 4.411). ISSN 1420-3049 (Online) DOI: 10.3390/molecules26144304
  3. BILAN, D.Y., SUCMAN, N.S., RADUL, O.M., DRAGALIN, I.P., BARBA, A.N., MACAEV, F. Synthesis of (–)-convolutamydine a derivatives and analogs,  Natur. Comps.  2021, vol. 57, pp. 516-520. DOI: https://doi.org/10.1007/s10600-021-03400-3
  4. CURLAT, S.N., MACAEV, F. Synthesis of 1,2,3-Triazole-Substituted 3,7,7-Trimethylbicyclo[4.1.0]Heptanols Based on (+)-3-Carene. Natur. Comps. 2021, vol. 57, pp. 733-740. https://doi.org/10.1007/s10600-021-03461-4
  5. STINGACI, E.; ZVEAGHINTEVA, M.; POGREBNOI, S.; LUPASCU, L.; VALICA, V.; UNCU, L.; SMETANSCAIA, A.; DRUMEA, M.; PETROU, A.; CIRIC, A.; GLAMOCLIJA, J.; SOKOVIC, M.; KRAVTSOV, V.; GERONIKAKI, A.; MACAEV, F. New vinyl-1,2,4-triazole derivatives as antimicrobial agents: Synthesis, biological evaluation and molecular docking studies. Bioorganic & Medicinal Chemistry Letters. 2020, 30 (17), 127368. https://doi.org/10.1016/j.bmcl.2020.127368

Patents/Brevets

  1. Eremia, N., Macaev, F., Krasociko, P., Pogrebnoi, S., Znagovan, A., Neicovcena, I., CoƟeleva, O., Eremia, I., SarĂź, A. Procedeu de hrănire a albinelor.Brevet de invenție de scurtă durată. Chișinău, MD 1611 Y 2022.04.30. BIOPI nr. 4/2022.
  2. Eremia N., Macaev, F., Pogrebnoi, S., Znagovan, A., Modvala, S., Mardari T., Eremia, I., SarĂź, A. Procedeu de hrănire a albinelor. Brevet de invenție de scurtă durată. Chișinău, MD 1598 Z 2022.09.30. BIOPI nr. 4/2022.
  3. Eremia, N., Macaev, F., Krasociko, P., Pogrebnoi, S., Znagovan, A., Neicovcena, I., CoƟeleva, O., Eremia, I., SarĂź, A. Procedeu de hrănire a albinelor. Brevet de invenție de scurtă durată. Chișinău, MD 1611 Y 2022.04.30. BIOPI nr. 4/2022.
  4. Lupașcu, G., Macaev, F., Gavzer, S., Cristea, N., Lupașcu, L., StĂąngaci,  E.,  Pogrebnoi, V., Pogrebnoi, S. Procedeu de tratare a boabelor de grĂąu comun de toamnă. Brevet de invenĆŁie de scurtă durată MD №1604 B1 acordatdin 03.31. BOPI nr.3/2022
  5. Lupașcu, G., Macaev, F., Gavzer, S., Cristea, N., Lupașcu, L., StĂąngaci,  E.,  Zveaghințeva,  Pogrebnoi S. Procedeu de tratare a boabelor de grĂąu comun de toamnă. Brevet de invenĆŁie de scurtă durată MD № 1603 B1 acordat din 2022.03.31. BOPI nr. 3/2022
  6. Lupașcu, G., Macaev, F., Gavzer, S., Cristea, N., Lupașcu, L., StĂąngaci,  E., Zveaghințeva,, Pogrebnoi, S. Procedeu de tratare a boabelor de grĂąu comun de toamnă. Brevet de invenĆŁie de scurtă durată MD №1591 B1 acordat din 2022.01.31. BOPI nr. 1/2022
  7. Macaev, F.; StĂąngaci, E.; Pogrebnoi, S.; Boldescu, V. Metodă pentru sinteza 3,3-dialilindolin-2-onei. Institutul de Chimie. Brevet de invenție MD №4739B1, acordat din 01.31.
  8. Macaev,; StĂąngaci, E.;  Pogrebnoi, S.; Boldescu V. (Z) -5-metil-1- (4-nitrofenil) -2- (1H-1,2,4-triazol-1-il) hex-1-en-3-onă, procedeuƟi sinteză ei Ăźn calitate de remediu antifungic . Institutul de Chimie. Brevet de invenție MD № 4703C1., eliberat din 2020.07.31.
  9. Macaev, F.; Bilan, D.; Radul, O.; Boldescu, V. Procedeu de sinteza diastereo- și enantioselectivă a (S)-3-hidroxi-3-((R)-2-oxociclohexil) indolin-2-onei. Institutul de Chimie. Brevet de invenție MD № 4689C1., acordat din02.28. BOPI nr.2/2021
  10. Macaev, F.; Zveaghințeva, M.; StĂąngaci, E.; Pogrebnoi, S.; LupaƟcu, L. Utilizare a (Z)-4,4-dimetil-1-(4-nitrofenil)-2-(1H-1,2,4-triazol-1-il)pent-1-en-3-onei Ăźn calitate de ingredient activ contra bacteriilor fitopatogene. Institutul de Chimie. Brevet de invenție MD № 4740B1 acordat din02.28. BOPI nr.2/2021

Canan Uluoglu – Pharmacology – Best Researcher Award

Posted on by ScienceFatherLeave a Comment on Canan Uluoglu – Pharmacology – Best Researcher Award

Canan Uluoglu – Pharmacology – Best Researcher Award

Dr. Canan Uluoglu distinguished academic and researcher in the field Pharmacology. She was awarded a postdoctoral scholarship at Ferrara University, where she worked in the Department of Clinical and Experimental Medicine’s Molecular and Cellular Pharmacology Unit from 2000 to 2001.

Her committee memberships include serving as a member of the Turkish Health Ministry’s Drug Regulatory Commission from 2015 to 2017, being a part of the Gazi University Clinical Research Ethics Committee from 2003 to 2018, and participating in the Turkish Scientific and Technological Research Council (TUBITAK) from 2010 to 2014.

Her research interests encompass Basic and Clinical Pharmacology, Chronopharmacology, and Neuropharmacology.

 

🌐 Professional Profile

Educations📚📚📚

She completed her medical education at Gazi University School of Medicine in Ankara, Turkey, graduating in 1989. In 1998, she became a Research Assistant and earned her PhD from the Department of Pharmacology at the same institution. Her academic career progressed as she was appointed as an Associate Professor in the Department of Pharmacology in 2003. By 2009, she had achieved the rank of Professor in the same department, continuing her contributions to the field of pharmacology at Gazi University School of Medicine.

📝🔬Publications📝🔬
  • ZS Ercan, RK TĂŒrker, C Uluoğlu, Ö Yazar, H Zengil. “The effects of endothelin peptides in the rabbit isolated perfused kidney.” General Pharmacology. 25(7):1471-1476 (1994). ISSN: 0306-3623
  • U Hodoğlugil, C Uluoğlu, HZ GĂŒney, CZ GörgĂŒn, ZS Ercan, N Abacıoğlu, H Zengil. “Twenty-four-hour variations in the effect of nitrodilators in rat aorta: lack of influence of the endothelium”. Journal of Pharmacy and Pharmacology. 49(11):1102-1108 (1997). ISSN:2042-7158
  • HZ GĂŒney, U Hodoğlugil, C Uluoğlu, CZ GörgĂŒn, ZS Ercan, N Abacıoğlu, H Zengil. In vitro susceptibility rhythms. II. Biological-time-dependent differences in effect of b1 -and b2 – adrenergic agonists of rat aorta and influence of endothelium. Chronobiology International. 15(2): 159-172 (1998). Print ISSN: 0742-0528 Online ISSN: 1525-6073
  • C Uluoğlu, HZ GĂŒney, M Kılınç, ƞ Bozkurt, ZS Ercan. “The effects of captopril and naloxone on restraint-cold-stress- and ethanol-induced gastric lesions in rats.” General Pharmacology. 30(5):701-704 (1998). ISSN: 0306-3623
  • C Uluoğlu, U Hodoğlugil, HZ GĂŒney, CZ GörgĂŒn, N Abacıoğlu, H Zengil. “Daily variations in the responses to papaverine but not theophylline in rat aorta.” Biological Rhythm Research. 29(4): 343-352 (1998). ISSN: 0929-1016 Online ISSN: 1744-4179
  • C Uluoğlu, A Oğuz, Ö Timlioğlu, G Biberoğlu, A Hasanoğlu. “Intermediate dose of methotrexate toxicity in non-Hodgkin lymphoma.” General Pharmacology. 32(2): 215-218 (1999). ISSN: 0306-3623
  • U Hodoğlugil, ZA Keskil, CZ GörgĂŒn, C Uluoğlu, N Abacıoğlu, H Zengil. “Effect of time on endothelium-dependent relaxations in mice and rat thoracic aortas.” Biological Rhythm Research. 30(4): 434-444 (1999). Print ISSN: 0929-1016 Online ISSN: 1744-4179
  • O Uludağ, B Tunçtan, HZ GĂŒney, C Uluoğlu, S Altuğ, H Zengil, N Abacıoğlu. “Temporal variation in serum nitrite levels in rats and mice.” Chronobiology International.  16(4): 527-532 (1999). ISSN: 1525-6073
  • HZ GĂŒney, C Uluoğlu, U Hodoğlugil, CZ GörgĂŒn, T Yamanoğlu, N Abacıoğlu, H Zengil. “Biological-time-dependent differences in effect of verapamil in rat aorta and influence of endothelium.” Chronobiology International.  16(6): 779-787 (1999). ISSN: 1525-6073
  • C Uluoğlu, Timlioğlu Ö. “Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia-reperfusion: effects of antagonizing platelet activating factor (PAF). “Naunyn-Schmiedeberg’s Archives of Pharmacology. 360(3): 324-330 (1999).

Panagiotis Karanis – Biomedical Research – Best Researcher Award

Posted on by ScienceFatherLeave a Comment on Panagiotis Karanis – Biomedical Research – Best Researcher Award

Panagiotis Karanis – Biomedical Research

Dr. Panagiotis karanis  distinguished academic and researcher in the field Biomedical research, infectious diseases, climate changes.  Professor Karanis is a resourceful and dedicated professor with an impressive academic background,
excellent publication record and significant teaching experiences in the fields of Emerging Infectious
Parasitic and Tropical Diseases and Human Anatomy. Possesses excellent interpersonal and liaison skills
with the ability to build and maintain positive working relationships. Possesses mature administrative and
managerial skills and solid experience in science policy and public health. Enjoys worldwide collaborating
in a productive and successful team and thrives in challenging environments. He was 1000 Talent Plan
Expert (2014-2017) in Qinghai, China.

🌐 Professional Profiles

Educations: 📚🎓

Professor Dr. Panagiotis Karanis has held various esteemed positions in the field of anatomy and biomedicine, showcasing an extensive and distinguished career spanning several decades. From 2019 to the present, he serves as a Professor of Anatomy and the Coordinator of the Unit of Anatomy & Morphology at the Medical School, University of Nicosia, Nicosia, Cyprus. His contributions extend globally, as he has been an international advisor, consultant, and visiting professor at numerous universities.

During the period from 2014 to 2018, Professor Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at the State Key Laboratory for Plateau Ecology and Agriculture at Qinghai University in Xining, China. His expertise was recognized internationally, as he was selected as a Foreign Expert in the 1000 Talent Plan, Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese experts in China.

Earlier in his career, from 2009 to the present, Professor Karanis made significant contributions as a Professor of Anatomy at the Medical School, University of Cologne, Germany. Prior to this, he served as an Associate Professor and later as a Full Professor at the National Research Centre for Protozoan Diseases (NRCPD) in Japan from 2006 to 2007.

The trajectory of Professor Karanis’s career is marked by academic achievements. In 1999, he received Venia legendi in Parasitology (PD Dr.) and completed his Habilitation in Clinical-Theoretical Medicine at the Medical Faculty, University of Bonn, Germany. His academic journey began with a PhD in Parasitology, focusing on ‘UV-Disinfection of Protozoan Parasites’ at the University of Bonn in 1992. Earlier, in 1987, he earned a Diploma in Biology from the University of Bochum, Germany.

Professor Karanis’s educational background is diverse, including studies in Biology at the Universities of Bielefeld, DĂŒsseldorf, and Bochum from 1980 to 1986. He also pursued complementary studies of Medicine at the Universities of Bochum and Cologne, completing the pre-clinical medical curriculum. His commitment to academia and research has made him a respected figure in the international scientific community, contributing significantly to the fields of anatomy, biomedicine, and parasitology.

Research Interests: 🧬🔬

Biomedical research, infectious diseases, climate changes,Applications of Network Science and Graph Analytics in Social, Biological, and Technological Networks

Awards and Achievements: 🏆👏

  •  Prof. Karanis is included on the annual list of 100,000 top scientists worldwide and, correspondingly, in
    the top 2 per cent of scientists in their field, according to a team of researchers at Stanford University in
    the USA. The updated 2020 list is based on a range of citation metrics that provides standardized data
    across those fields and subfields, in arriving at the (2019) single year impact result of more than 8,000,000
    scientists worldwide.
  • Gained worldwide administrative and managerial skills and experiences in science policy and public
    health. Successfully established 5 Laboratories / Institutions in Bonn / Germany (Waterborne and Vectorborne
    Parasitic Diseases), Thessaloniki / Greece (Leishmania and Sandflies), Cologne / Germany (Medical and
    Molecular Parasitology), Obihiro / Japan (Unit for Diseases Control and Genetics), Xining / China (Centre
    of Biomedicine and Infectious Diseases; the laboratory was promoted from the Chinese Government toState Key Laboratory of the Qinghai Province in China, 2016). The laboratories in Germany, Japan and
    China achieved an international reputation
  • Developed worldwide effective cooperations between many countries, in particular betweenEuropean
    and Asian countries
  •  Consultant at Qatar National Research Foundation and Qatar University, Doha, Qatar
  • Academic program review for the Master of Science in Biomedical Science, College of Health
    Sciences at Qatar University, Doha, Qatar, September 2018
  • Consultant” at Walailak University, Nakhon Si Thammarat, Thailand
  • Nominated as “Advisory Board Member” of the “Centre of Excellence for Medical Research and
    Innovative Products (CEMRIP)” in Thailand.
  •  Nominated “National Distinguished Expert” and “State Specially Recruited Expert” of China
  • Selected in 1000 Talent Plan, the Recruitment Program of Foreign Experts (RPFE) for non-ethnic Chinese
    experts, China, 2014, leading into ongoing innovative and promising collaborations with China
  • Invitation for Short Term – Fellowship – Program for Malaria Research in Japan by JSPS (Japanese
    Society of Promotion of Science), 12th January – 11th March 2014

Career Summary 

Dr. Panagiotis Karanis is a distinguished parasitologist with a wealth of expertise and a prolific career spanning several prestigious institutions across the globe. Serving as a Guest Professor at the University of Padova in Italy during 2019 and 2020, as well as a Consultant at the College of Public Health in Qatar in 2018, he contributed significantly to the field of parasitology. Dr. Karanis has been a Consultant at Walailak University in Thailand since 2017, where he has provided guidance and international supervision for PhD students.

His academic endeavors include roles as an Invited Professor at the University of Alexandroupolis and the University of Ioannina in Greece, where he delivered lectures on infectious diseases to both undergraduate and postgraduate students. Notably, from 2014 to 2018, Dr. Karanis held the position of Professor and Director of the Centre of Biomedicine and Infectious Diseases at Qinghai University in China.

As a Foreign Expert in the 1000 Talent Plan Recruitment Program, he played a pivotal role in elevating the laboratory to the State Key Laboratory for Plateau Ecology and Agriculture of the Qinghai Province. Dr. Karanis’s contributions extended to advising the Chinese government on research ideas, particularly in waterborne and vectorborne diseases, and his efforts in developing Cryptosporidium culture assays for drug testing garnered recognition and funding from prestigious institutions such as the Bill and Melinda Gates Foundation. His comprehensive involvement in academia, research, and international collaborations underscores his commitment to advancing the field of parasitology and infectious diseases.

 

📚Top Noted Publication